1
|
Landolina M, Boriani G, Biffi M, Cattafi G, Capucci A, Dello Russo A, Facchin D, Rordorf R, Sagone A, Del Greco M, Morani G, Nicolis D, Meloni S, Grammatico A, Gasparini M. Determinants of worse prognosis in patients with cardiac resynchronization therapy defibrillators. Are ventricular arrhythmias an adjunctive risk factor? J Cardiovasc Med (Hagerstown) 2022; 23:42-48. [PMID: 34392257 DOI: 10.2459/jcm.0000000000001236] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
AIMS Cardiac resynchronization therapy (CRT) is indicated in patients with systolic heart failure (HF), severe left ventricle (LV) dysfunction and interventricular dyssynchrony.In prospective observational research, we aimed to evaluate whether CRT-induced LV reverse remodelling and occurrence of ventricular arrhythmias (VT/VF) independently contribute to prognosis in patients with CRT defibrillators (CRT-D). METHODS In 95 Italian cardiological centres, after a screening period of 6 months, patients were categorized according to VT/VF occurrence and CRT response, defined as LV end-systolic volume relative reduction >15% or LV ejection fraction absolute increase >5%. The main endpoint was death or HF hospitalizations. RESULTS Among 1308 CRT-D patients (80% male, mean age 66 years), at 6 months, follow-up 71% were identified as CRT responders and 12% experienced appropriate VT/VF detections. The main endpoint was significantly and independently associated with previous myocardial infarction, New York Heart Association Class, VT/VF occurrence and with CRT response. CRT nonresponder patients who suffered VT/VF in the screening period had a risk of death or HF hospitalizations [HR = 7.82, 95% confidence interval (CI) = 3.95-15.48] significantly (P < 0.001) higher than CRT responders without VT/VF occurrence. This risk is mitigated without VT/VF occurrence (HR = 3.47, 95% CI = 2.03-5.91, P < 0.001) or in case of CRT response (HR = 3.11, 95% CI = 1.44-6.72, P = 0.004). CONCLUSION Our data show that both CRT response and occurrence of VT/VF independently contribute to the risk of death or HF-related hospitalizations in CRT-D patients. Early VT/VF occurrence may be identified as a marker of disease severity than can be mitigated by CRT response both in terms of all-cause mortality and long-term VT/VF onset. CLINICAL TRIAL REGISTRATION URL: https://www.clinicaltrials.gov. Unique identifier: NCT00147290 and NCT00617175.
Collapse
Affiliation(s)
| | | | - Mauro Biffi
- Azienda Ospedaliero-Universitaria di Bologna, Bologna
| | | | | | | | | | | | - Antonio Sagone
- Università Statale di Milano (UNIMI), Facoltà di Medicina e Chirurgia, IRCCS Multimedica, Milan
| | | | | | | | | | | | | |
Collapse
|
2
|
Nagy KV, Széplaki G, Perge P, Boros AM, Kosztin A, Apor A, Molnár L, Szilágyi S, Tahin T, Zima E, Kutyifa V, Gellér L, Merkely B. Quality of life measured with EuroQol-five dimensions questionnaire predicts long-term mortality, response, and reverse remodelling in cardiac resynchronization therapy patients. Europace 2019; 20:1506-1512. [PMID: 29182734 PMCID: PMC6123937 DOI: 10.1093/europace/eux342] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2017] [Accepted: 11/03/2017] [Indexed: 11/17/2022] Open
Abstract
Aims There are previous studies on quality of life (QoL) in cardiac resynchronization therapy (CRT) patients; however, there are no data with the short EuroQol-five dimensions (EQ-5D) questionnaire predicting outcomes. We aimed to assess the predictive role of baseline QoL and QoL change at 6 months after CRT with EQ-5D on 5-year mortality and response. Methods and results In our prospective follow-up study, 130 heart failure (HF) patients undergoing CRT were enrolled. Clinical evaluation, echocardiography, and EQ-5D were performed at baseline and at 6 months of follow–up, continued to 5 years. Primary endpoint was all-cause mortality at 5 years. Secondary endpoints were (i) clinical response with at least one class improvement in New York Heart Association without HF hospitalization and (ii) reverse remodelling with 15% reduction in left ventricular end-systolic volume at 6 months. Fifty-four (41.5%) patients died during 5 years, 85 (65.3%) clinical responders were identified, and 63 patients (48.5%) had reverse remodelling. Baseline issues with mobility were associated with lower response [odds ratio (OR) 0.36, 95% confidence interval (CI) 0.16–0.84; P = 0.018]. Lack of reverse remodelling correlated with self-care issues at baseline (OR 0.10, 95% CI 0.01–0.94; P = 0.04). Furthermore, self-care difficulties [hazard ratio (HR) 2.39, 95% CI 1.17–4.86; P = 0.01) or more anxiety (HR 1.51, 95% CI 1.00–2.26; P = 0.04) predicted worse long-term survival. At 6 months, mobility (HR 3.95, 95% CI 1.89–8.20; P < 0.001), self-care (HR 7.69, 95% CI 2.23–25.9; P = 0.001), or ≥ 10% visual analogue scale (VAS) (HR 2.24, 95% CI 1.27–3.94; P = 0.005) improvement anticipated better survival at 5 years. Conclusion EuroQol-five dimension is a simple method assessing QoL in CRT population. Mobility issues at baseline are associated with lower clinical response, whereas self-care issues predict lack of reverse remodelling. Problems with mobility or anxiety before CRT and persistent issues with mobility, self-care, and VAS scale at 6 months predict adverse outcome.
Collapse
Affiliation(s)
- Klaudia Vivien Nagy
- Heart and Vascular Center, Semmelweis University, 68 Városmajor utca, Budapest, Hungary
| | - Gábor Széplaki
- Heart and Vascular Center, Semmelweis University, 68 Városmajor utca, Budapest, Hungary
| | - Péter Perge
- Heart and Vascular Center, Semmelweis University, 68 Városmajor utca, Budapest, Hungary
| | - András Mihály Boros
- Heart and Vascular Center, Semmelweis University, 68 Városmajor utca, Budapest, Hungary
| | - Annamária Kosztin
- Heart and Vascular Center, Semmelweis University, 68 Városmajor utca, Budapest, Hungary
| | - Astrid Apor
- Heart and Vascular Center, Semmelweis University, 68 Városmajor utca, Budapest, Hungary
| | - Levente Molnár
- Heart and Vascular Center, Semmelweis University, 68 Városmajor utca, Budapest, Hungary
| | - Szabolcs Szilágyi
- Heart and Vascular Center, Semmelweis University, 68 Városmajor utca, Budapest, Hungary
| | - Tamás Tahin
- Heart and Vascular Center, Semmelweis University, 68 Városmajor utca, Budapest, Hungary
| | - Endre Zima
- Heart and Vascular Center, Semmelweis University, 68 Városmajor utca, Budapest, Hungary
| | - Valentina Kutyifa
- Heart and Vascular Center, Semmelweis University, 68 Városmajor utca, Budapest, Hungary
| | - László Gellér
- Heart and Vascular Center, Semmelweis University, 68 Városmajor utca, Budapest, Hungary
| | - Béla Merkely
- Heart and Vascular Center, Semmelweis University, 68 Városmajor utca, Budapest, Hungary
| |
Collapse
|
3
|
Boriani G, Ziacchi M, Nesti M, Battista A, Placentino F, Malavasi VL, Diemberger I, Padeletti L. Cardiac resynchronization therapy: How did consensus guidelines from Europe and the United States evolve in the last 15 years? Int J Cardiol 2018; 261:119-129. [DOI: 10.1016/j.ijcard.2018.01.039] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/31/2017] [Revised: 11/04/2017] [Accepted: 01/11/2018] [Indexed: 12/20/2022]
|
4
|
Crespo-Leiro MG, Anker SD, Maggioni AP, Coats AJ, Filippatos G, Ruschitzka F, Ferrari R, Piepoli MF, Delgado Jimenez JF, Metra M, Fonseca C, Hradec J, Amir O, Logeart D, Dahlström U, Merkely B, Drozdz J, Goncalvesova E, Hassanein M, Chioncel O, Lainscak M, Seferovic PM, Tousoulis D, Kavoliuniene A, Fruhwald F, Fazlibegovic E, Temizhan A, Gatzov P, Erglis A, Laroche C, Mebazaa A. European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions. Eur J Heart Fail 2017; 18:613-25. [PMID: 27324686 DOI: 10.1002/ejhf.566] [Citation(s) in RCA: 517] [Impact Index Per Article: 73.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/08/2015] [Revised: 02/17/2016] [Accepted: 03/03/2016] [Indexed: 12/17/2022] Open
Abstract
AIMS The European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT-R) was set up with the aim of describing the clinical epidemiology and the 1-year outcomes of patients with heart failure (HF) with the added intention of comparing differences between participating countries. METHODS AND RESULTS The ESC-HF-LT-R is a prospective, observational registry contributed to by 211 cardiology centres in 21 European and/or Mediterranean countries, all being member countries of the ESC. Between May 2011 and April 2013 it collected data on 12 440 patients, 40.5% of them hospitalized with acute HF (AHF) and 59.5% outpatients with chronic HF (CHF). The all-cause 1-year mortality rate was 23.6% for AHF and 6.4% for CHF. The combined endpoint of mortality or HF hospitalization within 1 year had a rate of 36% for AHF and 14.5% for CHF. All-cause mortality rates in the different regions ranged from 21.6% to 36.5% in patients with AHF, and from 6.9% to 15.6% in those with CHF. These differences in mortality between regions are thought reflect differences in the characteristics and/or management of these patients. CONCLUSION The ESC-HF-LT-R shows that 1-year all-cause mortality of patients with AHF is still high while the mortality of CHF is lower. This registry provides the opportunity to evaluate the management and outcomes of patients with HF and identify areas for improvement.
Collapse
Affiliation(s)
- Maria G Crespo-Leiro
- Unidad de Insuficiencia Cardiaca Avanzada y Trasplante Cardiaco, Complexo Hospitalario Universitario A Coruna, CHUAC, La Coruna, Spain
| | - Stefan D Anker
- Innovative Clinical Trials, Department of Cardiology and Pneumology, University Medical Center Göttingen (UMG), Göttingen, Germany
| | - Aldo P Maggioni
- EURObservational Research Programme, European Society of Cardiology, Sophia-Antipolis, France.,ANMCO Research Centre, Florence, Italy
| | - Andrew J Coats
- Monash University, Australia and University of Warwick, Coventry, UK
| | | | - Frank Ruschitzka
- Department of Cardiology, Heart Failure Clinic and Transplantation, University Heart Centre Zurich, Zurich, Switzerland
| | - Roberto Ferrari
- Department of Cardiology and LTTA Centre, University Hospital of Ferrara and Maria Cecilia Hospital, GVM Care and Research, ES Health Science Foundation, Cotignola, Italy
| | | | | | - Marco Metra
- Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy
| | - Candida Fonseca
- Heart Failure Unit, S Francisco Xavier Hospital/CHLO NOVA Medical School, Faculdade de Ciências Medicas, Universidade Nova de Lisboa, Portugal
| | - Jaromir Hradec
- 3rd Department of Medicine, Faculty General Hospital, Charles University, Prague, Czech Republic
| | - Offer Amir
- Poriya Medical Centre and Faculty of Medicine Bar Ilan University, Israel
| | - Damien Logeart
- Assistance Publique Hôpitaux Paris, Hôpital Lariboisière, Université Paris Diderot, Inserm 942, Paris, France
| | - Ulf Dahlström
- Department of Cardiology and Department of Medical and Health Sciences, Linköping University, Linköping, Sweden
| | - Bela Merkely
- Semmelweis University, Heart Centre, Budapest, Hungary
| | - Jaroslaw Drozdz
- Department of Cardiology, Medical University of Lodz, Lodz, Poland
| | - Eva Goncalvesova
- Department of Heart Failure/Transplantation, National Cardiovascular Institute, Bratislava, Slovakia
| | | | - Ovidiu Chioncel
- Institutul De Urgente Boli Cardiovasculare CC Iliescu, Universitatea de Medicina Carol Davila, Bucuresti, Romania
| | - Mitja Lainscak
- Department of Cardiology, General Hospital Celje, Celje, Slovenia
| | - Petar M Seferovic
- University of Belgrade, School of Medicine, Department of Cardiology, Clinical Centre of Serbia
| | - Dimitris Tousoulis
- 1st Cardiology Department, Athens University Medical School, Athens, Greece
| | - Ausra Kavoliuniene
- Department of Cardiology, Lithuanian University of Health Sciences, Kaunas, Lithuania
| | | | - Emir Fazlibegovic
- Department of Internal Medicine, Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina
| | - Ahmet Temizhan
- Turkey Yüksek Ihtisas Hospital, Cardiology Clinic, Ankara, Turkey
| | | | - Andrejs Erglis
- Pauls Stradins Clinical University Hospital, Riga, Latvia
| | - Cécile Laroche
- EURObservational Research Programme, European Society of Cardiology, Sophia-Antipolis, France
| | - Alexandre Mebazaa
- Hôpital Lariboisière, Université Paris Diderot, Inserm 942, Paris, France
| | | |
Collapse
|
5
|
Abreu A, Oliveira M, Silva Cunha P, Santa Clara H, Portugal G, Gonçalves Rodrigues I, Santos V, Morais L, Selas M, Soares R, Branco L, Ferreira R, Mota Carmo M. Does permanent atrial fibrillation modify response to cardiac resynchronization therapy in heart failure patients? Rev Port Cardiol 2017; 36:687-694. [DOI: 10.1016/j.repc.2017.02.016] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2016] [Revised: 02/01/2017] [Accepted: 02/21/2017] [Indexed: 11/30/2022] Open
|
6
|
Does permanent atrial fibrillation modify response to cardiac resynchronization therapy in heart failure patients? REVISTA PORTUGUESA DE CARDIOLOGIA (ENGLISH EDITION) 2017. [DOI: 10.1016/j.repce.2017.02.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
7
|
Abstract
PURPOSE OF REVIEW Medical devices have become an integral part of comprehensive heart failure management. Not all heart failure patients, however, accrue benefit from every new device, and even with extensive practice guidelines, this remains an evolving field. RECENT FINDINGS The addition of implantable devices, like internal cardioverter defibrillators (ICDs), and novel pacing technologies, including cardiac resynchronization therapy (CRT), have helped to compliment goal-directed medical therapy and positively impact prognosis in multiple high-quality clinical trials. This review attempts to summarize the rapidly evolving literature with respect to existing device guidelines for routine implantable devices as well as some available and future technologies that are not yet a part of routine guidelines. ICD, CRT, and other implantable devices continue to save lives, decrease hospitalizations, and evolve the management of patients with heart failure beyond the capabilities of optimal guideline-directed medical therapy alone.
Collapse
Affiliation(s)
- Brett G Angel
- Division of Cardiology, Hahnemann University Hospital, Drexel University College of Medicine, 245 North 15th Street, Suite 6122, Philadelphia, PA, 19102, USA.
| | - Heath Saltzman
- Division of Cardiology, Hahnemann University Hospital, Drexel University College of Medicine, 245 North 15th Street, Suite 6122, Philadelphia, PA, 19102, USA
| | - Luke S Kusmirek
- Division of Cardiology, Hahnemann University Hospital, Drexel University College of Medicine, 245 North 15th Street, Suite 6122, Philadelphia, PA, 19102, USA
| |
Collapse
|
8
|
Chia PL, Foo D. Overview of implantable cardioverter defibrillator and cardiac resynchronisation therapy in heart failure management. Singapore Med J 2017; 57:354-9. [PMID: 27440409 DOI: 10.11622/smedj.2016117] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
Clinical trials have established the benefits of implantable cardioverter defibrillators (ICDs) and cardiac resynchronisation therapy (CRT) in the treatment of heart failure patients. As adjuncts to guideline-directed medical therapy, ICDs confer mortality benefits from sudden cardiac arrest, while CRT reduces mortality, hospitalisation rates and improves functional capacity. This review discusses the use of ICDs and CRT devices in heart failure management, outlining the evidence supporting their use, indications and contraindications.
Collapse
Affiliation(s)
- Pow-Li Chia
- Department of Cardiology, Tan Tock Seng Hospital, Singapore
| | - David Foo
- Department of Cardiology, Tan Tock Seng Hospital, Singapore
| |
Collapse
|
9
|
Podolecki T, Pudlo R, Mazurek M, Koziel M, Jedrzejczyk-Patej E, Boidol J, Przybylska K, Sokal A, Kowalski O, Kowalczyk J, Lenarczyk R, Kalarus Z. The Incidence, Clinical Significance, and Treatment Effects of Depression in Cardiac Resynchronization Therapy Recipients. Cardiology 2017. [DOI: 10.1159/000475522] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Objectives: Chronic heart failure (HF) is associated with significantly increased prevalence of depression. The aim of the study was to assess the incidence and clinical impact of depression as well as the effectiveness of depression treatment in HF patients. Methods: A prospective interventional trial included 285 consecutive cardiac resynchronization therapy recipients. Patients underwent a psychiatric examination at the time of implantation and then it was routinely repeated at 3, 6, and 12 months after the procedure, and every 6 months thereafter. One hundred and thirty-five (47.4%) patients with depression were included in the depression group, whereas the control group was comprised of 150 patients free of depression. Sixty-eight (50.4%) subjects received antidepressants (treated group), whereas the observational group had 67 (49.6%) depressed patients who refused to take antidepressants. Results: Depression remission was achieved in 51 (75.0%) patients from the treated group. Long-term mortality and HF hospitalization rates were significantly higher in the depression group than in the control group (20.7 vs. 11.3% and 32.6 vs. 19.2%, respectively). However, remission from depression was associated with a 40% reduction in the relative risk of major adverse cardiac events (MACE). Conclusions: Patients with HF and concomitant depression are at higher risk of MACE compared with those free of depression. Effective antidepressant treatment may significantly improve long-term outcomes in this population.
Collapse
|
10
|
Jorsal A, Kistorp C, Holmager P, Tougaard RS, Nielsen R, Hänselmann A, Nilsson B, Møller JE, Hjort J, Rasmussen J, Boesgaard TW, Schou M, Videbaek L, Gustafsson I, Flyvbjerg A, Wiggers H, Tarnow L. Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial. Eur J Heart Fail 2016; 19:69-77. [PMID: 27790809 DOI: 10.1002/ejhf.657] [Citation(s) in RCA: 337] [Impact Index Per Article: 42.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/26/2016] [Revised: 08/17/2016] [Accepted: 08/19/2016] [Indexed: 12/11/2022] Open
Abstract
AIMS To determine the effect of the glucagon-like peptide-1 analogue liraglutide on left ventricular function in chronic heart failure patients with and without type 2 diabetes. METHODS AND RESULTS LIVE was an investigator-initiated, randomised, double-blinded, placebo-controlled multicentre trial. Patients (n = 241) with reduced left ventricular ejection fraction (LVEF ≤45%) were recruited (February 2012 to August 2015). Patients were clinically stable and on optimal heart failure treatment. Intervention was liraglutide 1.8 mg once daily or matching placebo for 24 weeks. The LVEF was similar at baseline in the liraglutide and the placebo group (33.7 ± 7.6% vs. 35.4 ± 9.4%). Change in LVEF did not differ between the liraglutide and the placebo group; mean difference (95% confidence interval) was -0.8% (-2.1, 0.5; P = 0.24). Heart rate increased with liraglutide [mean difference: 7 b.p.m. (5, 9), P < 0.0001]. Serious cardiac events were seen in 12 (10%) patients treated with liraglutide compared with 3 (3%) patients in the placebo group (P = 0.04). CONCLUSION Liraglutide did not affect left ventricular systolic function compared with placebo in stable chronic heart failure patients with and without diabetes. Treatment with liraglutide was associated with an increase in heart rate and more serious cardiac adverse events, and this raises some concern with respect to the use of liraglutide in patients with chronic heart failure and reduced left ventricular function. More data on the safety of liraglutide in different subgroups of heart failure patients are needed.
Collapse
Affiliation(s)
- Anders Jorsal
- Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.,Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark
| | - Caroline Kistorp
- Department of Endocrinology and Internal Medicine, Herlev University Hospital, Copenhagen, Denmark.,Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
| | - Pernille Holmager
- Department of Endocrinology and Internal Medicine, Herlev University Hospital, Copenhagen, Denmark
| | - Rasmus Stilling Tougaard
- Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.,Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark
| | - Roni Nielsen
- Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.,Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark
| | - Anja Hänselmann
- Department of Cardiology, Odense University Hospital, Odense, Denmark
| | - Brian Nilsson
- Department of Cardiology, Hvidovre University Hospital, Copenhagen, Denmark
| | | | - Jakob Hjort
- Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark
| | - Jon Rasmussen
- Department of Endocrinology and Internal Medicine, Herlev University Hospital, Copenhagen, Denmark.,Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
| | | | - Morten Schou
- Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.,Department of Cardiology, Herlev and Gentofte University Hospital, Copenhagen, Denmark
| | - Lars Videbaek
- Department of Cardiology, Odense University Hospital, Odense, Denmark
| | - Ida Gustafsson
- Department of Cardiology, Hvidovre University Hospital, Copenhagen, Denmark
| | - Allan Flyvbjerg
- Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark.,Faculty of Health, Aarhus University, Aarhus, Denmark.,Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark
| | - Henrik Wiggers
- Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.,Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark
| | - Lise Tarnow
- Steno Diabetes Center, Gentofte, Denmark.,Faculty of Health, Aarhus University, Aarhus, Denmark.,Nordsjaellands University Hospital, Hillerød, Denmark
| |
Collapse
|
11
|
Comparison between IEGM-based approach and echocardiography in AV/PV and VV delay optimization in CRT-D recipients (Quicksept study). Indian Pacing Electrophysiol J 2016; 16:59-65. [PMID: 27676162 PMCID: PMC5832617 DOI: 10.1016/j.ipej.2016.05.001] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2015] [Revised: 04/14/2016] [Accepted: 05/31/2016] [Indexed: 11/24/2022] Open
Abstract
BACKGROUND AtrioVentricular (AV) and InterVentricular (VV) delay optimization can improve ventricular function in Cardiac Resynchronization Therapy (CRT) and is usually performed by means of echocardiography. St Jude Medical has developed an automated algorhythm which calculates the optimal AV and VV delays (QuickOpt™) based on Intracardiac ElectroGrams, (IEGM), within 2 min. So far, the efficacy of the algorhythm has been tested acutely with standard lead position at right ventricular (RV) apex. Aim of this project is to evaluate the algorhythm performance in the mid- and long-term with RV lead located in mid-septum. METHODS AV and VV delays optimization data were collected in 13 centers using both echocardiographic and QuickOpt™ guidance in CRTD implanted patients provided with this algorhythm. Measurements of the aortic Velocity Time Integral (aVTI) were performed with both methods in a random order at pre-discharge, 6-month and 12-month follow-up. RESULTS Fifty-three patients were studied (46 males; age 68 ± 10y; EF 28 ± 7%). Maximum aVTI obtained by echocardiography at different AV delays, were compared with aVTI acquired at AV delays suggested by QuickOpt. The AV Pearson correlations were 0.96 at pre-discharge, 0.95 and 0,98 at 6- and 12- month follow-up respectively. After programming optimal AV, the same approach was used to compare echocardiographic aVTI with aVTI corresponding to the VV values provided by QuickOpt. The VV Pearson Correlation were 0,92 at pre-discharge, 0,88 and 0.90 at 6-month and 12- month follow-up respectively. CONCLUSIONS IEGM-based optimization provides comparable results with echocardiographic method (maximum aVTI) used as reference with mid-septum RV lead location.
Collapse
|
12
|
Hollingworth W, Biswas M, Maishman RL, Dayer MJ, McDonagh T, Purdy S, Reeves BC, Rogers CA, Williams R, Pufulete M. The healthcare costs of heart failure during the last five years of life: A retrospective cohort study. Int J Cardiol 2016; 224:132-138. [PMID: 27648982 DOI: 10.1016/j.ijcard.2016.09.021] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/17/2016] [Revised: 08/22/2016] [Accepted: 09/12/2016] [Indexed: 10/21/2022]
Abstract
BACKGROUND Evidence on the economic impact of heart failure (HF) is vital in order to predict the cost-effectiveness of novel interventions. We estimate the health system costs of HF during the last five years of life. METHODS We used linked primary care and mortality data accessed through the Clinical Practice Research Datalink (CPRD) to identify 1555 adults in England who died with HF in 2012/13. We used CPRD and linked Hospital Episode Statistics to estimate the cost of medications, primary and hospital healthcare. Using GLS regression we estimated the relationship between costs, HF diagnosis, proximity to death and patient characteristics. RESULTS In the last 3months of life, healthcare costs were £8827 (95% CI £8357 to £9296) per patient, more than 90% of which were for inpatient or critical care. In the last 3months, patients spent on average 17.8 (95% CI 16.8 to 18.8) days in hospital and had 8.8 (95% CI 8.4 to 9.1) primary care consultations. Most (931/1555; 59.9%) patients were in hospital on the day of death. Mean quarterly healthcare costs in quarters after HF diagnosis were higher (£1439; [95% CI £1260 to £1619]) than in quarters preceding diagnosis. Older patients and patients with lower comorbidity scores had lower costs. CONCLUSIONS Healthcare costs increase sharply at the end of life and are dominated by hospital care. There is potential to save money by implementation and evaluation of interventions that are known to reduce hospitalisations for HF, particularly at the end of life.
Collapse
Affiliation(s)
| | - Mousumi Biswas
- School of Social and Community Medicine, University of Bristol, Bristol, UK
| | - Rachel L Maishman
- Clinical Trials and Evaluation Unit, School of Clinical Sciences, University of Bristol, Bristol, UK
| | - Mark J Dayer
- Department of Cardiology, Taunton and Somerset NHS Foundation Trust, Taunton, UK
| | | | - Sarah Purdy
- School of Social and Community Medicine, University of Bristol, Bristol, UK
| | - Barnaby C Reeves
- Clinical Trials and Evaluation Unit, School of Clinical Sciences, University of Bristol, Bristol, UK
| | - Chris A Rogers
- Clinical Trials and Evaluation Unit, School of Clinical Sciences, University of Bristol, Bristol, UK
| | - Rachael Williams
- Clinical Practice Research Datalink, Medicines and Healthcare products Regulatory Agency, London, UK
| | - Maria Pufulete
- Clinical Trials and Evaluation Unit, School of Clinical Sciences, University of Bristol, Bristol, UK
| |
Collapse
|
13
|
Sousa GR, Costa HS, Souza AC, Nunes MCP, Lima MMO, Rocha MODC. Health-related quality of life in patients with Chagas disease: a review of the evidence. Rev Soc Bras Med Trop 2016; 48:121-8. [PMID: 25992924 DOI: 10.1590/0037-8682-0244-2014] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2014] [Accepted: 01/13/2015] [Indexed: 11/21/2022] Open
Abstract
Chagas disease (ChD), a neglected tropical disease caused by infection with the parasite Trypanosoma cruzi (T. cruzi), remains a serious public health issue in Latin America and is an emerging disease in several non-endemic countries, where knowledge of the condition and experience with its clinical management are limited. Regionally, the disease is the major cause of disability secondary to tropical diseases in young adults. Health-related quality of life (HRQoL) impairment is common in patients with ChD, especially in those with Chagas dilated cardiomyopathy, the most severe manifestation of the disease, which frequently leads to heart failure. The aim of this review was to conduct a literature search for studies that have evaluated the determining factors of HRQoL in ChD patients. We included cross-sectional, case-control, cohort, and experimental studies, as well as clinical trials that evaluated the HRQoL in ChD patients aged 18 to 60 years and are presenting an explicit description of statistical analysis. Using a combination of keywords based on Descriptors in Health Sciences (DeCS) and Medical Subject Headings (MeSH) for searches in PubMed and the Scientific Electronic Library Online (SciELO), 148 studies were found. After exclusions, 12 studies were selected for analysis. Three main findings were extracted from these studies: 1) cardiac involvement is associated with a worse HRQoL in ChD patients; 2) HRQoL is associated with the patients' functional capacity; and 3) simple and inexpensive therapeutic measures are effective for improving HRQoL in ChD patients. Hence, ChD patients' functional capacity, the effectiveness of non-surgical conservative treatment, and cardiac involvement are important determining factors for the HRQoL in ChD patients.
Collapse
Affiliation(s)
- Giovane Rodrigo Sousa
- Programa de Pós-Graduação em Ciências da Saúde: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
| | - Henrique Silveira Costa
- Programa de Pós-Graduação em Ciências da Saúde: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
| | - Aline Cristina Souza
- Programa de Pós-Graduação em Ciências da Saúde: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
| | - Maria Carmo Pereira Nunes
- Programa de Pós-Graduação em Ciências da Saúde: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
| | - Márcia Maria Oliveira Lima
- Departamento de Fisioterapia, Faculdade Ciências Biológicas e da Saúde, Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina, Minas Gerais, Brazil
| | - Manoel Otávio da Costa Rocha
- Programa de Pós-Graduação em Ciências da Saúde: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
| |
Collapse
|
14
|
Ventricular antitachycardia pacing therapy in patients with heart failure implanted with a cardiac resynchronization therapy defibrillator device: Efficacy, safety, and impact on mortality. Heart Rhythm 2016; 13:472-80. [DOI: 10.1016/j.hrthm.2015.10.022] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/20/2015] [Indexed: 11/20/2022]
|
15
|
Lunati M, Proclemer A, Boriani G, Landolina M, Locati E, Rordorf R, Daleffe E, Ricci RP, Catanzariti D, Tomasi L, Gulizia M, Baccillieri MS, Molon G, Gasparini M. Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database. Europace 2016; 18:1391-8. [PMID: 26826135 DOI: 10.1093/europace/euv420] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2015] [Accepted: 11/18/2015] [Indexed: 11/14/2022] Open
Abstract
AIMS Implantable cardioverter defibrillators improve survival of patients at risk for ventricular arrhythmias, but inappropriate shocks occur in up to 30% of patients and have been associated with worse quality of life and prognosis. In heart failure patients with cardiac resynchronization therapy defibrillators (CRT-Ds), we evaluated whether a new generation of detection and discrimination algorithms reduces inappropriate shocks. METHODS AND RESULTS We analysed 1983 Medtronic CRT-D patients (80% male, 67 ± 10 years), 1368 with standard devices (Control CRT-D) and 615 with new generation devices (New CRT-D). Expert electrophysiologists reviewed and classified the electrograms of all device-detected ventricular tachycardia/fibrillation episodes. Total follow-up was 3751 patients-years. Incidence of inappropriate shocks at 1 year was 2.8% [95% confidence interval (CI) = 2.0-3.5] in Control CRT-D and 0.9% (CI = 0.4-2.2) in New CRT-D (hazard ratio = 0.37, CI = 0.21-0.66, P < 0.001). In New CRT-D, inappropriate shocks were reduced by 77% [incidence rate ratio (IRR) = 0.23, CI = 0.16-0.35, P < 0.001] and inappropriate anti-tachycardia pacing by 81% (IRR = 0.19, CI = 0.11-0.335, P < 0.001). Annual rate per 100 patient-years for appropriate VF detections was 3.0 (CI = 2.1-4.2) in New CRT-D and 3.2 (CI = 2.1-5.0) in Control CRT-D (P = 0.68), for syncope was 0.4 (CI = 0.2-0.9) in New CRT-D and 0.7 (CI = 0.5-1.0) in Control CRT-D (P = 0.266), and for death was 1.0 (CI = 0.6-1.6) in New CRT-D and 3.5 (CI = 3.0-4.1) in Control CRT-D (P < 0.001). CONCLUSION Detection and discrimination algorithms used in new generation CRT-D significantly reduced inappropriate shocks when compared with standard CRT-D. This result, with no compromise on VF sensitivity or risk of syncope, has important implications for patients' quality of life and prognosis.
Collapse
Affiliation(s)
- Maurizio Lunati
- 'A De Gasperis' Cardiac Department, Niguarda Ca' Granda Hospital, Piazza Ospedale Maggiore, 3, 20162 Milano, Italy
| | | | - Giuseppe Boriani
- University of Bologna and Azienda Ospedaliera S.Orsola-Malpighi, Bologna, Italy
| | - Maurizio Landolina
- Fondazione Policlinico S. Matteo IRCCS, Pavia, Italy Ospedale Maggiore, Crema (Cremona), Italy
| | - Emanuela Locati
- 'A De Gasperis' Cardiac Department, Niguarda Ca' Granda Hospital, Piazza Ospedale Maggiore, 3, 20162 Milano, Italy
| | | | | | | | | | - Luca Tomasi
- Azienda Ospedaliera Universitaria Integrata, Verona, Italy
| | | | | | - Giulio Molon
- Ospedale Sacro Cuore Don Calabria, Negrar, Italy
| | | | | |
Collapse
|
16
|
Buja L, Schoen F. The Pathology of Cardiovascular Interventions and Devices for Coronary Artery Disease, Vascular Disease, Heart Failure, and Arrhythmias. Cardiovasc Pathol 2016. [DOI: 10.1016/b978-0-12-420219-1.00032-x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
|
17
|
Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck KH, Hernandez-Madrid A, Nikolaou N, Norekvål TM, Spaulding C, Van Veldhuisen DJ. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Europace 2015; 17:1601-87. [PMID: 26318695 DOI: 10.1093/europace/euv319] [Citation(s) in RCA: 217] [Impact Index Per Article: 24.1] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
|
18
|
Sullivan BL, Bartels K, Hamilton N. Insertion and Management of Temporary Pacemakers. Semin Cardiothorac Vasc Anesth 2015; 20:52-62. [PMID: 26134176 DOI: 10.1177/1089253215584923] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Temporary pacemakers are used in a variety of critical care settings. These life-saving devices are reviewed in 2 major categories in this review: first, the insertion and management of epicardial pacemakers after and during cardiac surgery; and second, the insertion of transvenous temporary pacemakers for the emergent treatment of bradyarrhythmias. Temporary epicardial pacemakers are used routinely in patients recovering from cardiac surgery. Borrowing from advances in cardiac resynchronization therapy there are many theoretical and untested benefits to pacing the postoperative cardiac surgery patient. Temporary transvenous pacing is traditionally an emergency procedure to stabilize patients suffering from hemodynamically unstable bradyarrhythmia. We review the traditional and expanding use of transvenous pacemakers inside and outside the operating room.
Collapse
|
19
|
Niazi IK, Sperzel J, Heist EK, Rosenberg SP, Ryu K, Yang M, D'Avila A, Singh JP. Three-Dimensional Cardiac Mapping Characterizes Ventricular Contractile Patterns during Cardiac Resynchronization Therapy Implant: A Feasibility Study. PACING AND CLINICAL ELECTROPHYSIOLOGY: PACE 2015; 38:1091-8. [PMID: 26096125 DOI: 10.1111/pace.12674] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/05/2014] [Revised: 05/04/2015] [Accepted: 06/01/2015] [Indexed: 11/30/2022]
Abstract
BACKGROUND Electroanatomic mapping systems track the position of electrodes in the heart. We assessed the feasibility of characterizing left ventricular (LV) performance during cardiac resynchronization therapy (CRT) implant utilizing an electroanatomic mapping system to track the motion of CRT lead electrodes, thus deriving ventricular contractility surrogates. METHODS During CRT implant, atrial, right ventricular (RV), and LV leads were connected to the EnSite NavX™ mapping system (St. Jude Medical Inc., St. Paul, MN, USA). The relative displacement of electrodes was averaged over 10 cardiac cycles during RV, LV, and biventricular (BiV) pacing in DOO mode. Three contractility surrogates indicative of ventricular performance were extracted from the RV-LV distance waveform: systolic slope (SS), time to peak systolic contraction (TPSC), and fractional shortening (FS). RESULTS In the 20 patients included, there were detectable differences in each of the three contractility surrogates responding to the different pacing configurations. Median SS varied 42%, median TPSC varied 35%, and median FS varied 19% across RV, LV, and BiV pacing interventions. The RV-LV distance waveform showed subtle sensitivity to varying pacing timing cycles when measured in a subset of patients. For all pacing configurations, RV-LV distance waveforms were stable during 2-minute recordings. CONCLUSIONS Tracking the motion of CRT pacing electrodes with a mapping system to derive contractility surrogates during implant is feasible.
Collapse
Affiliation(s)
- Imran K Niazi
- Aurora Cardiovascular Services, Aurora Sinai/Aurora St. Luke's Medical Centers, University of Wisconsin School of Medicine and Public Health, Milwaukee, Wisconsin
| | | | | | | | | | | | - Andre D'Avila
- Massachusetts General Hospital, Boston, Massachusetts
| | | |
Collapse
|
20
|
|
21
|
Abstract
There are still many aspects of heart failure care for which gaps remain in the evidence base, resulting in gaps in the guidelines. We aim to highlight these guideline gaps including areas that warrant further research and other areas where new data are forthcoming.
Collapse
Affiliation(s)
- Bao Tran
- Ahmanson-UCLA Cardiomyopathy Center, Ronald Reagan-UCLA Medical Center, Los Angeles,California, USA
| | - Gregg C Fonarow
- Ahmanson-UCLA Cardiomyopathy Center, Ronald Reagan-UCLA Medical Center, Los Angeles,California, USA
| |
Collapse
|
22
|
Steffel J, Holzmeister J, Abraham WT. Recent Advances in Cardiac Resynchronization Therapy. Postgrad Med 2015; 123:18-26. [DOI: 10.3810/pgm.2011.03.2259] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
|
23
|
Buikema JW, Van Der Meer P, Sluijter JPG, Domian IJ. Concise review: Engineering myocardial tissue: the convergence of stem cells biology and tissue engineering technology. Stem Cells 2015; 31:2587-98. [PMID: 23843322 DOI: 10.1002/stem.1467] [Citation(s) in RCA: 36] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2013] [Revised: 05/09/2013] [Accepted: 05/14/2013] [Indexed: 12/11/2022]
Abstract
Advanced heart failure represents a leading public health problem in the developed world. The clinical syndrome results from the loss of viable and/or fully functional myocardial tissue. Designing new approaches to augment the number of functioning human cardiac muscle cells in the failing heart serve as the foundation of modern regenerative cardiovascular medicine. A number of clinical trials have been performed in an attempt to increase the number of functional myocardial cells by the transplantation of a diverse group of stem or progenitor cells. Although there are some encouraging suggestions of a small early therapeutic benefit, to date, no evidence for robust cell or tissue engraftment has been shown, emphasizing the need for new approaches. Clinically meaningful cardiac regeneration requires the identification of the optimum cardiogenic cell types and their assembly into mature myocardial tissue that is functionally and electrically coupled to the native myocardium. We here review recent advances in stem cell biology and tissue engineering and describe how the convergence of these two fields may yield novel approaches for cardiac regeneration.
Collapse
Affiliation(s)
- Jan Willem Buikema
- Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA; Department of Cardiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
| | | | | | | |
Collapse
|
24
|
Haver VG, Verweij N, Kjekshus J, Fox JC, Wedel H, Wikstrand J, van Gilst WH, de Boer RA, van Veldhuisen DJ, van der Harst P. The impact of coronary artery disease risk loci on ischemic heart failure severity and prognosis: association analysis in the COntrolled ROsuvastatin multiNAtional trial in heart failure (CORONA). BMC MEDICAL GENETICS 2014; 15:140. [PMID: 25528061 PMCID: PMC4412120 DOI: 10.1186/s12881-014-0140-3] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 06/23/2014] [Accepted: 12/11/2014] [Indexed: 11/10/2022]
Abstract
BACKGROUND Recent genome-wide association studies have identified multiple loci that are associated with an increased risk of developing coronary artery disease (CAD). The impact of these loci on the disease severity and prognosis of ischemic heart failure due to CAD is currently unknown. METHODS We undertook association analysis of 7 single nucleotide polymorphism (rs599839, rs17465637, rs2972147, rs6922269, rs1333049, rs501120, and rs17228212) at 7 well established CAD risk loci (1p13.3, 1q41, 2q36.3, 6q25.1, 9p21.3, 10q11.21, and 15q22.33, respectively) in 3,320 subjects diagnosed with systolic heart failure of ischemic aetiology and participating in the COntrolled ROsuvastatin multiNAtional Trial in Heart Failure (CORONA) trial. The primary outcome was the composite of time to first event of cardiovascular death, non-fatal myocardial infarction and non-fatal stroke, secondary outcomes included mortality and hospitalization due to worsening heart failure. RESULTS None of the 7 loci were significantly associated with the primary composite endpoint of the CORONA trial (death from cardiovascular cases, nonfatal myocardial infarction, and nonfatal stroke). However, the 1p13.3 locus (rs599839) showed evidence for association with all-cause mortality (after adjustment for covariates; HR 0.74, 95%CI [0.61 to 0.90]; P = 0.0025) and we confirmed the 1p13.3 locus (rs599839) to be associated with lipid parameters (total cholesterol (P = 1.1x10(-4)), low-density lipoprotein levels (P = 3.5 × 10(-7)) and apolipoprotein B (P = 2.2 × 10(-10))). CONCLUSION Genetic variants strongly associated with CAD risk are not associated with the severity and outcome of ischemic heart failure. The observed association of the 1p13.3 locus with all-cause mortality requires confirmation in further studies.
Collapse
Affiliation(s)
- Vincent G Haver
- University of Groningen, University Medical Center Groningen, Department of Cardiology, Hanzeplein 1, 9713GZ, Groningen, The Netherlands.
| | - Niek Verweij
- University of Groningen, University Medical Center Groningen, Department of Cardiology, Hanzeplein 1, 9713GZ, Groningen, The Netherlands.
| | - John Kjekshus
- Department of Cardiology, University of Oslo and Oslo University Hospital, Oslo, Norway.
| | - Jayne C Fox
- AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK.
| | - Hans Wedel
- Nordic School of Public Health, Göteborg, Sweden.
| | - John Wikstrand
- Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden.
| | - Wiek H van Gilst
- University of Groningen, University Medical Center Groningen, Department of Cardiology, Hanzeplein 1, 9713GZ, Groningen, The Netherlands.
| | - Rudolf A de Boer
- University of Groningen, University Medical Center Groningen, Department of Cardiology, Hanzeplein 1, 9713GZ, Groningen, The Netherlands.
| | - Dirk J van Veldhuisen
- University of Groningen, University Medical Center Groningen, Department of Cardiology, Hanzeplein 1, 9713GZ, Groningen, The Netherlands.
| | - Pim van der Harst
- University of Groningen, University Medical Center Groningen, Department of Cardiology, Hanzeplein 1, 9713GZ, Groningen, The Netherlands. .,University of Groningen, University Medical Center Groningen, Department of Genetics, Hanzeplein 1, 9713GZ, Groningen, The Netherlands. .,Durrer Center for Cardiogenetic Research, ICIN-Netherlands Heart Institute, 3511GC, Utrecht, The Netherlands.
| |
Collapse
|
25
|
Kienemund J, Kuck KH, Frerker C. Cardiac Resynchronisation Therapy or MitraClip® Implantation for Patients with Severe Mitral Regurgitation and Left Bundle Branch Block? Arrhythm Electrophysiol Rev 2014; 3:190-3. [PMID: 26835090 DOI: 10.15420/aer.2014.3.3.190] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/04/2014] [Accepted: 11/18/2014] [Indexed: 11/04/2022] Open
Abstract
Secondary or functional mitral regurgitation (FMR) is a common problem in patients with chronic heart failure (HF). About one-third of patients with chronic HF also have left bundle branch block (LBBB). Approximately one-third of patients with an indication for cardiac resynchronisation therapy (CRT) have moderate-to-severe FMR. This FMR may either be a consequence of systolic dysfunction or it may occur due to dyssynchrony. Both directly reducing FMR and correcting cardiac dyssynchrony are viable therapeutic approaches in selected patients, according to the 2012 European Society of Cardiology (ESC) Guidelines for valvular heart disease. Initial presence of FMR is an independent predictor of lack of clinical response to CRT. Patients undergoing CRT without signs of significant clinical improvement may be considered candidates for the percutaneous MitraClip® procedure. As yet, there are not enough data to select patients that would benefit from being treated primarily with MitraClip. A clinical trial in HF patients to be randomised to either MitraClip procedure or CRT is needed to confirm actual ESC Guideline therapy.
Collapse
Affiliation(s)
- Jens Kienemund
- Department of Cardiology, Asklepios Clinic St. Georg, Hamburg, Germany
| | - Karl-Heinz Kuck
- Department of Cardiology, Asklepios Clinic St. Georg, Hamburg, Germany
| | - Christian Frerker
- Department of Cardiology, Asklepios Clinic St. Georg, Hamburg, Germany
| |
Collapse
|
26
|
Bitter T, Gutleben KJ, Nölker G, Dimitriadis Z, Prinz C, Vogt J, Horstkotte D, Oldenburg O. Sleep-disordered breathing and inappropriate defibrillator shocks in chronic heart failure. Herzschrittmacherther Elektrophysiol 2014; 25:198-205. [PMID: 25070930 DOI: 10.1007/s00399-014-0324-8] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2014] [Accepted: 06/04/2014] [Indexed: 06/03/2023]
Abstract
PURPOSE Supraventricular tachyarrhythmias are a major cause of inappropriate defibrillator shocks. Sleep-disordered breathing (SDB) is a known risk factor for atrial fibrillation (AF). We hypothesized that Cheyne-Stokes respiration (CSA) and obstructive sleep apnea (OSA) have an impact on inappropriate defibrillator discharges in patients witch chronic heart failure (CHF) and cardiac resynchronization therapy with defibrillator (CRT-D). METHODS In this study, 172 patients with CHF (LVEF ≤ 45 %, NYHA-class ≥ 2) and CRT-D underwent overnight polygraphy; 54 had no SDB (apnea-hypopnea index < 5/h), 59 had OSA, and 59 had CSA. During follow-up (36 months), inappropriate defibrillator shocks were documented. RESULTS In all, 17 patients had inappropriate defibrillator shocks (9.9 %; eight oversensing due to lead fractures, five caused by atrial fibrillation, four because of sinus tachycardia). Mean event-free survival time was 33.5 ± 1.2 months in the CSA group, 35.2 ± 0.7 months in the OSA group, and 32.1 ± 1.5 months in the no SDB group, respectively (CSA vs. no SDB p = 0.63; OSA vs. no SDB p = 0.31; CSA vs. OSA p = 0.45). Stepwise Cox proportional hazard regression analysis revealed an independent association for age (per year: hazard ratio 0.90, 95 % confidence interval 0.85-0.96, p < 0.001), but not for any kind of SDB. CONCLUSIONS SDB was not associated with inappropriate defibrillator shocks. We assume this is due to the low incidenceand low proportion of inappropriate therapies in response to AF.
Collapse
Affiliation(s)
- Thomas Bitter
- Department of Cardiology, Heart and Diabetes Center North Rhine-Westphalia, Ruhr University Bochum, Georgstraße 11, 32545, Bad Oeynhausen, Germany,
| | | | | | | | | | | | | | | |
Collapse
|
27
|
Abstract
In June 2012, the New Guidelines for the Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology were published. According to the EMPHASIS-HF trial, mineralocorticoid receptor antagonists are indicated in all stages of symptomatic chronic heart failure under treatment with β-blockers and ACE inhibitors. Based on the SHIFT trial, patients with class NYHA II-IV heart failure, an ejection fraction <35%, and sinus rhythm with a heart rate of >70/min despite pharmacological treatment including β-blockers at the maximum tolerated dose should be treated with ivabradin. The RAFT trial justified the extended indication for CRT systems. In acute heart failure, the RELAX-AHF trial showed promising results with serelaxin. This manuscript summarizes the innovations of the new guidelines and the underlying clinical trials.
Collapse
Affiliation(s)
- J Pöss
- Klinik für Innere Medizin III, Kardiologie, Angiologie und internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Kirrbergerstr., 66421, Homburg/Saar, Deutschland,
| | | | | |
Collapse
|
28
|
Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, Deaton C, Escaned J, Hammes HP, Huikuri H, Marre M, Marx N, Mellbin L, Ostergren J, Patrono C, Seferovic P, Uva MS, Taskinen MR, Tendera M, Tuomilehto J, Valensi P, Zamorano JL. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary. Diab Vasc Dis Res 2014; 11:133-73. [PMID: 24800783 DOI: 10.1177/1479164114525548] [Citation(s) in RCA: 141] [Impact Index Per Article: 14.1] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
|
29
|
Dewhurst MJ, Linker NJ. Current Evidence and Recommendations for Cardiac Resynchronisation Therapy. Arrhythm Electrophysiol Rev 2014; 3:9-14. [PMID: 26835058 DOI: 10.15420/aer.2011.3.1.9] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/05/2013] [Accepted: 03/13/2014] [Indexed: 11/04/2022] Open
Abstract
The number of people in Europe living with symptomatic heart failure is increasing. Since its advent in the 1990s, cardiac resynchronisation therapy (CRT) has proven beneficial in terms of morbidity and mortality in selected heart failure (HF) patient populations, when combined with optimal pharmacological therapy. We review the evidence for CRT and the populations of HF patients it is currently shown to benefit, and those in which more research needs to be performed.
Collapse
Affiliation(s)
| | - Nicholas J Linker
- Consultant Cardiologist, The James Cook University Hospital, Middlesbrough, UK
| |
Collapse
|
30
|
Ricci RP, Pignalberi C, Landolina M, Santini M, Lunati M, Boriani G, Proclemer A, Facchin D, Catanzariti D, Morani G, Gulizia M, Mangoni L, Grammatico A, Gasparini M. Ventricular rate monitoring as a tool to predict and prevent atrial fibrillation-related inappropriate shocks in heart failure patients treated with cardiac resynchronisation therapy defibrillators. Heart 2014; 100:848-54. [DOI: 10.1136/heartjnl-2013-305259] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
|
31
|
Tarazón E, Roselló-Lletí E, Rivera M, Ortega A, Molina-Navarro MM, Triviño JC, Lago F, González-Juanatey JR, Orosa P, Montero JA, Salvador A, Portolés M. RNA sequencing analysis and atrial natriuretic peptide production in patients with dilated and ischemic cardiomyopathy. PLoS One 2014; 9:e90157. [PMID: 24599027 PMCID: PMC3943898 DOI: 10.1371/journal.pone.0090157] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2013] [Accepted: 01/26/2014] [Indexed: 01/08/2023] Open
Abstract
BACKGROUND The atrium is the major site of ANP synthesis, which has been said to increase in heart failure as a result of increased production in the left ventricular (LV) myocardium. This is a key issue related to its diagnostic and prognostic capabilities. We aimed to evaluate protein levels of proANP and ANP and the enzymes that cleave the natriuretic peptides, corin and furin, in the LV tissue of heart transplant patients with dilated (DCM) and ischemic (ICM) cardiomyopathy compared with control donors (CNT). We also evaluate mRNA levels of ANP gene (NPPA) by RNA sequencing in the same tissue. METHODS AND RESULTS Seventy-three human LV tissue samples from ICM (n=30) and DCM (n=33) patients and CNT (n=10) were analyzed by Western blot and RNA sequencing. Comparing protein levels according to etiology, neither DCM nor ICM showed levels of proANP or ANP different from those of CNT. However, NPPA was increased in both groups compared to CNT (DCM 32 fold, p<0.0001; ICM 10 fold, p<0.0001). Corin (but not furin) was elevated in the ICM group compared to CNT (112 ± 24 vs. 100 ± 7, p<0.05), and its level was inversely related with LV ejection fraction (LVEF) (r=-0.399, p<0.05). CONCLUSIONS Patients present with elevated levels of NPPA but not of proANP or ANP proteins in LV tissue, which may be due to posttranscripcional regulation of NPPA or different pathways for ANP secretion between the atrium and ventricle. Moreover, there are differences between DCM and ICM in corin levels, indicating that a different molecular mechanism may exist that converge in this syndrome. Further, LV concentration of corin is inversely related to LVEF in ICM.
Collapse
Affiliation(s)
- Estefanía Tarazón
- Cardiocirculatory Unit, Instituto de Investigación Sanitaria Hospital Universitario La Fe, Valencia, Spain
| | - Esther Roselló-Lletí
- Cardiocirculatory Unit, Instituto de Investigación Sanitaria Hospital Universitario La Fe, Valencia, Spain
| | - Miguel Rivera
- Cardiocirculatory Unit, Instituto de Investigación Sanitaria Hospital Universitario La Fe, Valencia, Spain
| | - Ana Ortega
- Cardiocirculatory Unit, Instituto de Investigación Sanitaria Hospital Universitario La Fe, Valencia, Spain
| | | | | | - Francisca Lago
- Cellular and Molecular Cardiology Research Unit, Department of Cardiology and Institute of Biomedical Research, University Clinical Hospital, Santiago de Compostela, Spain
| | - José Ramón González-Juanatey
- Cellular and Molecular Cardiology Research Unit, Department of Cardiology and Institute of Biomedical Research, University Clinical Hospital, Santiago de Compostela, Spain
| | - Placido Orosa
- Cardiology Unit, Hospital San Francesc de Borja, Gandía, Spain
| | | | - Antonio Salvador
- Heart Failure and Transplantation Unit, Cardiology Department, Hospital Universitario La Fe, Valencia, Spain
| | - Manuel Portolés
- Cardiocirculatory Unit, Instituto de Investigación Sanitaria Hospital Universitario La Fe, Valencia, Spain
- * E-mail:
| |
Collapse
|
32
|
Gabrielli L, Marincheva G, Bijnens B, Doltra A, Tolosana JM, Borras R, Castel MA, Berruezo A, Brugada J, Mont L, Sitges M. Septal flash predicts cardiac resynchronization therapy response in patients with permanent atrial fibrillation. Europace 2014; 16:1342-9. [DOI: 10.1093/europace/euu023] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
33
|
Petretta M, Petretta A, Pellegrino T, Nappi C, Cantoni V, Cuocolo A. Role of nuclear cardiology for guiding device therapy in patients with heart failure. World J Meta-Anal 2014; 2:1-16. [DOI: 10.13105/wjma.v2.i1.1] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/25/2013] [Revised: 11/20/2013] [Accepted: 12/19/2013] [Indexed: 02/05/2023] Open
Abstract
Heart failure is a dynamic condition with high morbidity and mortality and its prognosis should be reassessed frequently, particularly in patients for whom critical treatment decisions may depend on the results of prognostication. In patients with heart failure, nuclear cardiology techniques are useful to establish the etiology and the severity of the disease, while fewer studies have explored the potential capability of nuclear cardiology to guide cardiac resynchronization therapy (CRT) and to select patients for implantable cardioverter defibrillators (ICD). Left ventricular synchrony may be assessed by radionuclide angiography or gated single-photon emission computed tomography myocardial perfusion scintigraphy. These modalities have shown promise as predictors of CRT outcome using phase analysis. Combined assessment of myocardial viability and left ventricular dyssynchrony is feasible using positron emission tomography and could improve conventional response prediction criteria for CRT. Preliminary data also exists on integrated positron emission tomography/computed tomography approach for assessing myocardial viability, identifying the location of biventricular pacemaker leads, and obtaining left ventricular functional data, including contractile phase analysis. Finally, cardiac imaging with autonomic radiotracers may be useful in predicting CRT response and for identifying patients at risk for sudden cardiac death, therefore potentially offering a way to select patients for both CRT and ICD therapy. Prospective trials where imaging is combined with image-test driven therapy are needed to better define the role of nuclear cardiology for guiding device therapy in patients with heart failure.
Collapse
|
34
|
Maass AH, Yu CM. Biventricular pacing in pacemaker dependency: one size does not fit all. Eur J Heart Fail 2014; 13:599-601. [DOI: 10.1093/eurjhf/hfr058] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Alexander H. Maass
- Department of Cardiology, Thoraxcenter; University Medical Center Groningen, University of Groningen; P.O. Box 30.001 9700 RB Groningen The Netherlands
| | - Cheuk-Man Yu
- Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital; The Chinese University of Hong Kong; Hong Kong China
| |
Collapse
|
35
|
Gudmundsson K, Lyngå P, Karlsson H, Rosenqvist M, Braunschweig F. Midsummer Eve in Sweden: a natural fluid challenge in patients with heart failure. Eur J Heart Fail 2014; 13:1172-7. [DOI: 10.1093/eurjhf/hfr124] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
Affiliation(s)
- Kristjan Gudmundsson
- Karolinska Institutet, Department of Cardiology; Karolinska University Hospital; Stockholm Sweden
| | - Patrik Lyngå
- Karolinska Institutet, Department of Cardiology; Södersjukhuset; Stockholm Sweden
| | - Helena Karlsson
- Karolinska Institutet, Department of Cardiology; Karolinska University Hospital; Stockholm Sweden
| | - Mårten Rosenqvist
- Karolinska Institutet, Department of Cardiology; Södersjukhuset; Stockholm Sweden
| | - Frieder Braunschweig
- Karolinska Institutet, Department of Cardiology; Karolinska University Hospital; Stockholm Sweden
| |
Collapse
|
36
|
Kristiansen H, Vollan G, Hovstad T, Keilegavlen H, Faerestrand S. A randomized study of haemodynamic effects and left ventricular dyssynchrony in right ventricular apical vs. high posterior septal pacing in cardiac resynchronization therapy. Eur J Heart Fail 2014; 14:506-16. [DOI: 10.1093/eurjhf/hfr162] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- H.M. Kristiansen
- Department of Heart Disease; Haukeland University Hospital; 5021 Bergen Norway
- Institute of Medicine, University of Bergen; Bergen Norway
| | - G. Vollan
- Department of Heart Disease; Haukeland University Hospital; 5021 Bergen Norway
| | - T. Hovstad
- Department of Heart Disease; Haukeland University Hospital; 5021 Bergen Norway
| | - H. Keilegavlen
- Department of Heart Disease; Haukeland University Hospital; 5021 Bergen Norway
| | - S. Faerestrand
- Department of Heart Disease; Haukeland University Hospital; 5021 Bergen Norway
- Institute of Medicine, University of Bergen; Bergen Norway
| |
Collapse
|
37
|
La Rovere MT, Pinna GD, Maestri R, Barlera S, Bernardinangeli M, Veniani M, Nicolosi GL, Marchioli R, Tavazzi L. Autonomic markers and cardiovascular and arrhythmic events in heart failure patients: still a place in prognostication? Data from the GISSI-HF trial. Eur J Heart Fail 2014; 14:1410-9. [DOI: 10.1093/eurjhf/hfs126] [Citation(s) in RCA: 54] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
Affiliation(s)
- Maria Teresa La Rovere
- Divisione di Cardiologia, e Bioingegneria, Fondazione ‘Salvatore Maugeri’, IRCCS; Istituto Scientifico di Montescano; Montescano Italy
| | - Gian Domenico Pinna
- Divisione di Cardiologia, e Bioingegneria, Fondazione ‘Salvatore Maugeri’, IRCCS; Istituto Scientifico di Montescano; Montescano Italy
| | - Roberto Maestri
- Divisione di Cardiologia, e Bioingegneria, Fondazione ‘Salvatore Maugeri’, IRCCS; Istituto Scientifico di Montescano; Montescano Italy
| | - Simona Barlera
- Dipartimento di Ricerca Cardiovascolare; Istituto Mario Negri; Milano Italy
| | | | | | | | | | - Luigi Tavazzi
- GVM Care and Research; Maria Cecilia Hospital Cotignola; (Ravenna) Italy
| | | |
Collapse
|
38
|
Winter J, Brack KE, Ng GA. Cardiac contractility modulation in the treatment of heart failure: initial results and unanswered questions. Eur J Heart Fail 2014; 13:700-10. [DOI: 10.1093/eurjhf/hfr042] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- James Winter
- Department of Cardiovascular Sciences; University of Leicester; Clinical Sciences Wing, Glenfield Hospital Leicester LE3 9QP UK
| | - Kieran E. Brack
- Department of Cardiovascular Sciences; University of Leicester; Clinical Sciences Wing, Glenfield Hospital Leicester LE3 9QP UK
| | - G. André Ng
- Department of Cardiovascular Sciences; University of Leicester; Clinical Sciences Wing, Glenfield Hospital Leicester LE3 9QP UK
- Leicester NIHR Biomedical Research Unit in Cardiovascular Disease; Glenfield Hospital; Leicester LE3 9QP UK
| |
Collapse
|
39
|
Cleland JG, Freemantle N, Erdmann E, Gras D, Kappenberger L, Tavazzi L, Daubert JC. Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) trial. Eur J Heart Fail 2014; 14:628-34. [DOI: 10.1093/eurjhf/hfs055] [Citation(s) in RCA: 99] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- John G.F. Cleland
- Department of Cardiology; Castle Hill Hospital, University of Hull; Kingston upon Hull UK
| | | | - Erland Erdmann
- Klinik III für Innere Medizin der Universität zu Köln; Cologne Germany
| | - Daniel Gras
- Nouvelles Cliniques Nantaises; Nantes France
| | | | - Luigi Tavazzi
- GVM Care and Research, Maria Cecilia Hospital; Cotignola Italy
| | | |
Collapse
|
40
|
Stockburger M, Gómez-Doblas JJ, Lamas G, Alzueta J, Fernández-Lozano I, Cobo E, Wiegand U, de la Concha JF, Navarro X, Navarro-López F, de Teresa E. Preventing ventricular dysfunction in pacemaker patients without advanced heart failure: results from a multicentre international randomized trial (PREVENT-HF). Eur J Heart Fail 2014; 13:633-41. [DOI: 10.1093/eurjhf/hfr041] [Citation(s) in RCA: 82] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Martin Stockburger
- Charité - Universitaetsmedizin Berlin, Experimental and Clinical Research Center (ECRC) Campus Berlin-Buch & Medizinische Klinik mit Schwerpunkt Kardiologie und Angiologie; Campus Mitte, Charitéplatz 1, 10117; Berlin Germany
| | - Juan José Gómez-Doblas
- Hospital Clínico Virgen de la Victoria; Campus Universitario Teatinos; 29010 Málaga Spain
| | - Gervasio Lamas
- Division of Cardiology; Mount Sinai Medical Center, Columbia University; FL 33140 USA
| | - Javier Alzueta
- Hospital Clínico Virgen de la Victoria; Campus Universitario Teatinos; 29010 Málaga Spain
| | | | - Erik Cobo
- Universidad Politécnica de Catalunya; C/ Pau Gargallo, 5 08028 Barcelona Spain
| | - Uwe Wiegand
- Universitaetsklinikum Schleswig-Holstein; Campus Luebeck, Ratzeburger Allee 160 23538 Luebeck Germany
| | | | - Xavier Navarro
- Medtronic Ibérica, S.A., C/ María de Portugal, 11; Madrid Spain
| | - Francisco Navarro-López
- Hospital Clínic i Provincial de Barcelona, Universidad de Barcelona; Villaroel 170 Barcelona Spain
| | - Eduardo de Teresa
- Hospital Clínico Virgen de la Victoria; Campus Universitario Teatinos; 29010 Málaga Spain
| |
Collapse
|
41
|
Prevalence of potential cardiac resynchronization therapy candidates and actual use of cardiac resynchronization therapy in patients hospitalized for heart failure. Eur J Heart Fail 2014; 13:412-5. [DOI: 10.1093/eurjhf/hfq217] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
42
|
Affiliation(s)
- Marcus J. Hof
- Department of Cardiology, Thoraxcenter; University of Groningen, University Medical Center Groningen; PO Box 30.001 9700 RB Groningen The Netherlands
| | - Alexander H. Maass
- Department of Cardiology, Thoraxcenter; University of Groningen, University Medical Center Groningen; PO Box 30.001 9700 RB Groningen The Netherlands
| |
Collapse
|
43
|
Lewinter C, Torp-Pedersen C, Cleland JG, Køber L. Right and left bundle branch block as predictors of long-term mortality following myocardial infarction. Eur J Heart Fail 2014; 13:1349-54. [DOI: 10.1093/eurjhf/hfr130] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
Affiliation(s)
- Christian Lewinter
- Academic Cardiology; Castle Hill Hospital, Hull York Medical School (HYMS); Hull UK
| | | | - John G.F. Cleland
- Academic Cardiology; Castle Hill Hospital, Hull York Medical School (HYMS); Hull UK
| | - Lars Køber
- Department of Cardiology, Rigshospitalet; University of Copenhagen; Blegdamsvej 9, 2100 København Denmark
| |
Collapse
|
44
|
Affiliation(s)
- Iwan C.C. van der Horst
- Thorax Center, Department of Cardiology; University Medical Center Groningen, University of Groningen; Hanzeplein 1 PO Box 30001, 9700 RB Groningen The Netherlands
| | - Cees J. Tack
- Department of Internal Medicine; Radboud University Medical Center Nijmegen; Nijmegen The Netherlands
| |
Collapse
|
45
|
Mouquet F, Mostefa Kara M, Lamblin N, Coulon C, Langlois S, Marquie C, de Groote P. Unexpected and rapid recovery of left ventricular function in patients with peripartum cardiomyopathy: impact of cardiac resynchronization therapy. Eur J Heart Fail 2014; 14:526-9. [DOI: 10.1093/eurjhf/hfs031] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- Frederic Mouquet
- Service de Cardiologie, Pôle Cardio-vasculaire et Pulmonaire, Hôpital Cardiologique, CHRU Lille; 59037 Lille Cedex France
| | - Meriem Mostefa Kara
- Service de Cardiologie, Pôle Cardio-vasculaire et Pulmonaire, Hôpital Cardiologique, CHRU Lille; 59037 Lille Cedex France
| | - Nicolas Lamblin
- Service de Cardiologie, Pôle Cardio-vasculaire et Pulmonaire, Hôpital Cardiologique, CHRU Lille; 59037 Lille Cedex France
| | - Capucine Coulon
- Service de Gynécologie Obstétrique, Maternité Jeanne de Flandres, CHRU Lille.; Lille France
| | - Stephane Langlois
- Service de Gynécologie Obstétrique, Maternité Jeanne de Flandres, CHRU Lille.; Lille France
| | - Christelle Marquie
- Service de Cardiologie, Pôle Cardio-vasculaire et Pulmonaire, Hôpital Cardiologique, CHRU Lille; 59037 Lille Cedex France
| | - Pascal de Groote
- Service de Cardiologie, Pôle Cardio-vasculaire et Pulmonaire, Hôpital Cardiologique, CHRU Lille; 59037 Lille Cedex France
| |
Collapse
|
46
|
Lim P, Donal E, Lafitte S, Derumeaux G, Habib G, Réant P, Thivolet S, Lellouche N, Grimm RA, Gueret P. Multicentre study using strain delay index for predicting response to cardiac resynchronization therapy (MUSIC study). Eur J Heart Fail 2014; 13:984-91. [DOI: 10.1093/eurjhf/hfr073] [Citation(s) in RCA: 49] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Pascal Lim
- Cardiovascular department; Henri Mondor University Hospital (APHP and INSERM U841); Créteil France
| | - Erwan Donal
- Pontchaillou University Hospital; Rennes France
| | | | | | | | | | | | - Nicolas Lellouche
- Cardiovascular department; Henri Mondor University Hospital (APHP and INSERM U841); Créteil France
| | | | - Pascal Gueret
- Cardiovascular department; Henri Mondor University Hospital (APHP and INSERM U841); Créteil France
| |
Collapse
|
47
|
Smit MD, Maass AH, Hillege HL, Wiesfeld AC, Van Veldhuisen DJ, Van Gelder IC. Prognostic importance of natriuretic peptides and atrial fibrillation in patients receiving cardiac resynchronization therapy. Eur J Heart Fail 2014; 13:543-50. [PMID: 21330294 DOI: 10.1093/eurjhf/hfr006] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- Marcelle D. Smit
- Department of Cardiology, Thoraxcenter; University Medical Center Groningen, University of Groningen; PO Box 30,001 9700 RB Groningen The Netherlands
| | - Alexander H. Maass
- Department of Cardiology, Thoraxcenter; University Medical Center Groningen, University of Groningen; PO Box 30,001 9700 RB Groningen The Netherlands
| | - Hans L. Hillege
- Department of Cardiology, Thoraxcenter; University Medical Center Groningen, University of Groningen; PO Box 30,001 9700 RB Groningen The Netherlands
| | - Ans C.P. Wiesfeld
- Department of Cardiology, Thoraxcenter; University Medical Center Groningen, University of Groningen; PO Box 30,001 9700 RB Groningen The Netherlands
| | - Dirk J. Van Veldhuisen
- Department of Cardiology, Thoraxcenter; University Medical Center Groningen, University of Groningen; PO Box 30,001 9700 RB Groningen The Netherlands
| | - Isabelle C. Van Gelder
- Department of Cardiology, Thoraxcenter; University Medical Center Groningen, University of Groningen; PO Box 30,001 9700 RB Groningen The Netherlands
- Interuniversity Cardiology Institute of The Netherlands; Utrecht The Netherlands
| |
Collapse
|
48
|
Shanks M, Antoni ML, Hoke U, Bertini M, Ng AC, Auger D, Marsan NA, van Erven L, Holman ER, Schalij MJ, Bax JJ, Delgado V. The effect of cardiac resynchronization therapy on left ventricular diastolic function assessed with speckle-tracking echocardiography. Eur J Heart Fail 2014; 13:1133-9. [DOI: 10.1093/eurjhf/hfr115] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Miriam Shanks
- Department of Cardiology; Leiden University Medical Center; Albinusdreef 2 2333 ZA Leiden The Netherlands
- Mazankowski Alberta Heart Institute; Edmonton Canada
| | - M. Louisa Antoni
- Department of Cardiology; Leiden University Medical Center; Albinusdreef 2 2333 ZA Leiden The Netherlands
| | - Ulas Hoke
- Department of Cardiology; Leiden University Medical Center; Albinusdreef 2 2333 ZA Leiden The Netherlands
| | - Matteo Bertini
- Department of Cardiology; Leiden University Medical Center; Albinusdreef 2 2333 ZA Leiden The Netherlands
- University of Ferrara, Ferrara and Fundation S. Maugeri Centro di Lumezzane; Brescia Italy
| | - Arnold C.T. Ng
- Department of Cardiology; Leiden University Medical Center; Albinusdreef 2 2333 ZA Leiden The Netherlands
- Princess Alexandra Hospital; University of Queensland; Brisbane Australia
| | - Dominique Auger
- Department of Cardiology; Leiden University Medical Center; Albinusdreef 2 2333 ZA Leiden The Netherlands
- Centre Hospitalier de l'Université de Montréal; Montréal Québec Canada
| | - Nina Ajmone Marsan
- Department of Cardiology; Leiden University Medical Center; Albinusdreef 2 2333 ZA Leiden The Netherlands
| | - Lieselot van Erven
- Department of Cardiology; Leiden University Medical Center; Albinusdreef 2 2333 ZA Leiden The Netherlands
| | - Eduard R. Holman
- Department of Cardiology; Leiden University Medical Center; Albinusdreef 2 2333 ZA Leiden The Netherlands
| | - Martin J. Schalij
- Department of Cardiology; Leiden University Medical Center; Albinusdreef 2 2333 ZA Leiden The Netherlands
| | - Jeroen J. Bax
- Department of Cardiology; Leiden University Medical Center; Albinusdreef 2 2333 ZA Leiden The Netherlands
| | - Victoria Delgado
- Department of Cardiology; Leiden University Medical Center; Albinusdreef 2 2333 ZA Leiden The Netherlands
| |
Collapse
|
49
|
Ciampi Q, Pratali L, Citro R, Villari B, Picano E, Sicari R. Additive value of severe diastolic dysfunction and contractile reserve in the identification of responders to cardiac resynchronization therapy. Eur J Heart Fail 2014; 13:1323-30. [DOI: 10.1093/eurjhf/hfr132] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/01/2023] Open
Affiliation(s)
- Quirino Ciampi
- Division of Cardiology, Fatebenefratelli Hospital; Viale Principe di Napoli, 12; I-82100 Benevento Italy
| | | | - Rodolfo Citro
- Division of Cardiology; San Leonardo Hospital; Salerno Italy
| | - Bruno Villari
- Division of Cardiology, Fatebenefratelli Hospital; Viale Principe di Napoli, 12; I-82100 Benevento Italy
| | | | - Rosa Sicari
- CNR; Institute of Clinical Physiology; Pisa Italy
| |
Collapse
|
50
|
Affiliation(s)
- Kevin Damman
- Department of Cardiology; University Medical Centre Groningen; PO Box 30.001, 9700 RB Groningen The Netherlands
| | - Alexander H. Maass
- Department of Cardiology; University Medical Centre Groningen; PO Box 30.001, 9700 RB Groningen The Netherlands
| | - Peter van der Meer
- Department of Cardiology; University Medical Centre Groningen; PO Box 30.001, 9700 RB Groningen The Netherlands
| |
Collapse
|